Skip to main content
Equibles

Michael Ryan

Board Member

Coherus Oncology, Inc. (CHRS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Coherus Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get CHRS alerts

About Michael Ryan

Michael Ryan is recorded as Board Member at Coherus Oncology, Inc. (CHRS) since April 23, 2025. Coherus Oncology, Inc. reported in an 8-K filed April 25, 2025 that Michael Ryan was appointed Class II director, effective April 23, 2025. Coherus Oncology, Inc. reported in an 8-K filed April 25, 2025 that Michael Ryan resigned as Class III director, effective April 23, 2025. Coherus Oncology, Inc. reported in an 8-K filed July 20, 2023 that Michael Ryan was appointed Class III director, effective July 18, 2023. Coherus Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coherus Oncology, Inc. includes Dennis Lanfear (CEO), Bryan McMichael (CFO and Chief Accounting Officer), Alan C. Mendelson (Board Member) and 6 others.

“On April 23, 2025 the Board accepted Ms. Karachun's resignation and immediately reappointed her as a Class I director and accepted Mr. Ryan's resignation and immediately reappointed him as a Class II director.”
Coherus Oncology, Inc. Form 8-K, filed April 25, 2025 · Read the filing
“on April 23, 2025 Rita A. Karachun tendered her resignation to the Board as a Class II director subject to her immediate reappointment as a Class I director and on the same date Michael Ryan tendered his resignation to the Board as a Class III director subject to his immediate reappointment as a Class II director.”
Coherus Oncology, Inc. Form 8-K, filed April 25, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Coherus Oncology, Inc.

Recent activity